30045 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 02
00:00 UTC
|
MSFT
Microsoft
|
◎ Target | Michael Turrin ★★★☆☆ #1231 | Overweight | $700.00→ $725.00+3.6% |
|
Oct 02
00:00 UTC
|
MRSH
Marsh & McLennan Companies
|
◎ Target | Pablo Singzon ★★★☆☆ #1190 | Overweight | $212.00→ $215.00+1.4% |
|
Oct 02
00:00 UTC
|
MP
MP Materials
|
◎ Target | Ben Kallo ★★★★☆ #880 | Outperform | $80.00→ $65.00-18.8% |
|
Oct 02
00:00 UTC
|
MC
Moelis & Company
|
◎ Target | James Yaro ★★★☆☆ #2238 | Neutral | $71.00→ $62.00-12.7% |
|
Oct 02
00:00 UTC
|
LRCX
Lam Research
|
◎ Target | Craig Ellis ★★★★☆ #903 | Buy | $350.00→ $390.00+11.4% |
|
Oct 02
00:00 UTC
|
LQDA
Liquidia
|
◎ Target | Serge Belanger ★★★☆☆ #1399 | Buy | $110.00→ $72.00-34.5% |
|
Oct 02
00:00 UTC
|
LEVI
Levi Strauss & Co.
|
◎ Target | Blake Anderson ★★★★★ #148 | Buy | $27.00→ $25.00-7.4% |
|
Oct 02
00:00 UTC
|
LAZ
Lazard
|
◎ Target | Richard Ramsden ★★☆☆☆ #2705 | Sell | $42.00→ $36.00-14.3% |
|
Oct 02
00:00 UTC
|
JBL
Jabil
|
◎ Target | Tim Long ★★★☆☆ #1614 | Overweight | $426.00→ $378.00-11.3% |
|
Oct 02
00:00 UTC
|
JBL
Jabil
|
◎ Target | Paul Coster not yet tracked | Overweight | $425.00→ $430.00+1.2% |
|
Oct 02
00:00 UTC
|
INSP
Inspire Medical Systems
|
◎ Target | Shagun Singh not yet tracked | Sec→ r Perform | $60.00→ $75.00+25.0% |
|
Oct 02
00:00 UTC
|
INCY
Incyte
|
◎ Target | Derek Archila ★★★☆☆ #2092 | Equal Weight | $116.00→ $128.00+10.3% |
|
Oct 02
00:00 UTC
|
ILMN
Illumina
|
◎ Target | Subbu Nambi ★★★★★ #296 | Buy | $226.00→ $305.00+35.0% |
|
Oct 02
00:00 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Meta Marshall ★★★☆☆ #1167 | Overweight | $67.00→ $72.00+7.5% |
|
Oct 02
00:00 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Asiya Merchant ★★☆☆☆ #2290 | Buy | $76.00→ $92.00+21.1% |
|
Oct 02
00:00 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Tim Long ★★★☆☆ #1614 | Overweight | $79.00→ $83.00+5.1% |
|
Oct 02
00:00 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Joe Quatrochi not yet tracked | Equal Weight | $54.00→ $63.00+16.7% |
|
Oct 02
00:00 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | David Vogt ★★★☆☆ #1699 | Neutral | $59.00→ $66.00+11.9% |
|
Oct 02
00:00 UTC
|
HLMN
Hillman Solutions
|
◎ Target | Brian McNamara ★★★☆☆ #2046 | Buy | $14.00→ $13.00-7.1% |
|
Oct 02
00:00 UTC
|
GSHD
Goosehead Insurance
|
◎ Target | Pablo Singzon ★★★☆☆ #1190 | Neutral | $68.00→ $60.00-11.8% |
|
Oct 02
00:00 UTC
|
GRG
Greggs
|
◎ Target | firm only | Buy | GBX 2,200→ GBX 2,300+4.5% |
|
Oct 02
00:00 UTC
|
GRAL
GRAIL
|
◎ Target | Subbu Nambi ★★★★★ #296 | Buy | $75.00→ $155.00+106.7% |
|
Oct 02
00:00 UTC
|
GMED
Globus Medical
|
◎ Target | Shagun Singh not yet tracked | Outperform | $115.00→ $85.00-26.1% |
|
Oct 02
00:00 UTC
|
GH
Guardant Health
|
◎ Target | Subbu Nambi ★★★★★ #296 | Buy | $190.00→ $200.00+5.3% |
|
Oct 02
00:00 UTC
|
FMX
Fomento Economico Mexicano
|
◎ Target | Rodrigo Alcantara ★★★★☆ #594 | Neutral | $139.00→ $130.00-6.5% |
|
Oct 02
00:00 UTC
|
FLUT
Flutter Entertainment
|
◎ Target | Clark Lampen ★★★★☆ #738 | Buy | $113.00→ $110.00-2.7% |
|
Oct 02
00:00 UTC
|
FLG
Flagstar Bank, National Association
|
◎ Target | Anthony Elian ★★☆☆☆ #2302 | Neutral | $15.50→ $14.00-9.7% |
|
Oct 02
00:00 UTC
|
FHB
First Hawaiian
|
◎ Target | Matthew Clark ★★★★☆ #793 | Neutral | $30.00→ $27.00-10.0% |
|
Oct 02
00:00 UTC
|
FDS
FactSet Research Systems
|
◎ Target | Jason Haas not yet tracked | Underweight | $210.00→ $250.00+19.0% |
|
Oct 02
00:00 UTC
|
FDS
FactSet Research Systems
|
◎ Target | Shlomo Rosenbaum ★★★★☆ #635 | Hold | $254.00→ $292.00+15.0% |
|
Oct 02
00:00 UTC
|
FCNCA
First Citizens BancShares
|
◎ Target | Anthony Elian ★★☆☆☆ #2302 | Neutral | $2,450.00→ $2,300.00-6.1% |
|
Oct 02
00:00 UTC
|
EXPD
Expeditors International of Washington
|
◎ Target | Daniel Moore ★☆☆☆☆ #3120 | Neutral | $190.00→ $200.00+5.3% |
|
Oct 02
00:00 UTC
|
EVPL
Everplay Group
|
◎ Target | firm only | Buy | GBX 540→ GBX 580+7.4% |
|
Oct 02
00:00 UTC
|
ESI
Element Solutions
|
◎ Target | John Roberts not yet tracked | Neutral | $45.00→ $42.00-6.7% |
|
Oct 02
00:00 UTC
|
EMN
Eastman Chemical
|
◎ Target | John Roberts not yet tracked | Outperform | $85.00→ $80.00-5.9% |
|
Oct 02
00:00 UTC
|
ELF
e.l.f. Beauty
|
◎ Target | Olivia Tong ★☆☆☆☆ #2934 | Strong-Buy | $100.00→ $117.00+17.0% |
|
Oct 02
00:00 UTC
|
DT
Dynatrace
|
◎ Target | Radi Sultan ★★★☆☆ #1219 | Buy | $65.00→ $74.00+13.8% |
|
Oct 02
00:00 UTC
|
DND
Dye & Durham
|
◎ Target | firm only | Market Perform | C$4.00→ C$1.75-56.2% |
|
Oct 02
00:00 UTC
|
DKS
DICK'S Sporting Goods
|
◎ Target | Joseph Civello ★★★☆☆ #1955 | Hold | $135.00→ $128.00-5.2% |
|
Oct 02
00:00 UTC
|
DKNG
DraftKings
|
◎ Target | Clark Lampen ★★★★☆ #738 | Buy | $30.00→ $25.00-16.7% |
|
Oct 02
00:00 UTC
|
DHR
Danaher
|
◎ Target | Subbu Nambi ★★★★★ #296 | Buy | $200.00→ $250.00+25.0% |
|
Oct 02
00:00 UTC
|
CYRX
CryoPort
|
◎ Target | Subbu Nambi ★★★★★ #296 | Buy | $16.00→ $19.00+18.8% |
|
Oct 02
00:00 UTC
|
CUBI
Customers Bancorp
|
◎ Target | Anthony Elian ★★☆☆☆ #2302 | Overweight | $96.00→ $92.00-4.2% |
|
Oct 02
00:00 UTC
|
COLB
Columbia Banking System
|
◎ Target | Anthony Elian ★★☆☆☆ #2302 | Neutral | $35.00→ $33.00-5.7% |
|
Oct 02
00:00 UTC
|
CHCO
City
|
◎ Target | Will Jones ★★★☆☆ #1939 | Market Perform | $135.00→ $145.00+7.4% |
|
Oct 02
00:00 UTC
|
CCL
Carnival
|
◎ Target | Manuchekhr Narzulloev not yet tracked | Buy | $35.00→ $36.00+2.9% |
|
Oct 02
00:00 UTC
|
CCL
Carnival
|
◎ Target | John Staszak ★★★☆☆ #1758 | Buy | $35.00→ $30.00-14.3% |
|
Oct 02
00:00 UTC
|
CCL
Carnival
|
◎ Target | Trey Bowers ★★★☆☆ #1273 | Overweight | $36.00→ $34.00-5.6% |
|
Oct 02
00:00 UTC
|
CAN
Canaan
|
◎ Target | Nick Giles ★★★★☆ #340 | Buy | $2.00→ $1.50-25.0% |
|
Oct 02
00:00 UTC
|
CALM
Cal-Maine Foods
|
◎ Target | Pooran Sharma ★★★★☆ #361 | Equal Weight | $80.00→ $70.00-12.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.